Early Diagnosis Pathogenesis and Progression of Open Angle Glaucoma

  • STATUS
    Recruiting
  • participants needed
    2500
  • sponsor
    University of Erlangen-Nürnberg Medical School
Updated on 7 November 2020
Investigator
Robert Laemmer, MD
Primary Contact
University Eye Hospital (8.7 mi away) Contact
corrected visual acuity
glaucoma
pigmentary glaucoma
glaucoma suspect

Summary

The Erlangen Glaucoma Registry is a clinical registry for cross sectional and longitudinal observation of patients with open angle glaucoma (OAG) or glaucoma suspect, founded in 1991. The primary aim is the evaluation of diagnostic and prognostic validity of morphometrical, sensory and hemodynamical diagnostic procedures. No therapeutic studies are performed.

Description

Purpose: Detection of onset and progression of structural and functional damage due to glaucoma. Determination of rate and amount of progressive change due to glaucoma. Characterisation of the relationship between structural and functional change over time. Evaluation of predictive factors for the development and progression of glaucoma.

Details
Condition Ocular Hypertension, Primary Open Angle Glaucoma, Secondary Open Angle Glaucoma
Clinical Study IdentifierNCT00494923
SponsorUniversity of Erlangen-Nürnberg Medical School
Last Modified on7 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Open anterior chamber angle
Best corrected visual acuity 0.7 or better
Age between 18 and 65 years

Exclusion Criteria

Any eye disease other than glaucoma
Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
Myopic or hyperopic refractive error exceeding 8.0 diopters
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note